Obalon Therapeutics, Inc. and Sono Bello Announce Agreement to Offer Novel Weight Loss Treatment in Sono Bello Centers
November 02, 2017 16:06 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) and Sono Bello announced today that they had reached an agreement to begin offering the novel Obalon Balloon...
Obalon Schedules Third Quarter 2017 Financial Results Conference Call for November 3, 2017 at 8:30 a.m. Eastern Time
October 26, 2017 08:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...
Kelly Huang, Ph.D., Joins Obalon Therapeutics, Inc. Executive Team
September 07, 2017 08:58 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that Kelly Huang, Ph.D., has joined as its...
Obalon Announces Second Quarter 2017 Financial Results
August 02, 2017 07:59 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Upcoming Conference Presentation
July 31, 2017 08:45 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 31, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules Second Quarter 2017 Financial Results Conference Call for August 2, 2017 at 8:30 a.m. Eastern Time
July 27, 2017 07:50 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 27, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics, Inc. to Present at UBS Global Healthcare Conference
May 22, 2017 09:05 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 22, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Receives Regulatory Approvals to Commercialize in Select Middle East Markets
May 11, 2017 08:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces First Quarter 2017 Financial Results
May 10, 2017 08:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces First Quarter 2017 Financial Results Conference Call
May 05, 2017 09:02 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 05, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...